RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Total non-current assets

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$82.2B
P/E ratio
SummaryFinancials
Period EndTotal non-current assets (Million USD)YoY (%)
Dec 31, 202419,099+40.42%
Dec 31, 202313,601+2.03%
Dec 31, 202213,330+16.73%
Dec 31, 202111,420+54.65%
Dec 31, 20207,384+3.77%
Dec 31, 20197,116+34.60%
Dec 31, 20185,287+19.36%
Dec 31, 20174,429+16.77%
Dec 31, 20163,793+40.80%
Dec 31, 20152,694+58.07%
Dec 31, 20141,704+47.68%
Dec 31, 20131,154+31.97%
Dec 31, 2012874+30.38%
Dec 31, 2011671-8.35%
Dec 31, 2010732

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)